Maurico / MEDEC / COCIR / HIMA / IAPM / Tokyo / Zurich / Canberra / Dräger / Toronto / NEMA / /
Company
AEs / Baxter / Health / SG2 / New Subgroup / /
Continent
Europe / /
Country
Germany / Switzerland / Puerto Rico / New Zealand / Japan / United States / Canada / Australia / United Kingdom / / /
IndustryTerm
adverse event reporting systems / postmarket systems / /
Organization
Board of Health / A. Authority / FDA / European Union / MEDDEV / /
Person
Kevin Murray / Larry Kessler / Ben Khosravi / Derek Fitzgerald / Werner Schönbuhler / Pierre Landry / Emil Tschöpe / Axel Godeck / Carl Wallroth / Kazuhisa Hasebe / Denise Sofoulis / Jeffrey Dutton / Martin Bayreuther / Yvonne Aggett / Martin Van Lith / Arthur Brandwood / Mike Flood / Vivian Coates / Ken Kopesky / John Worroll / John Michalícek / Jean-Claude Bonnace / Deb Blum / Ian Campbell / Masato Yoshida / Joanna Bartholomeus / Roland Gerard / Tom Gross / Robert Virefléau / Trevor Nisbet / Masaaki Naito / Alan Kent / Gisela Ininger / Kim Dix / Jacob Nordan / Jim Collins / / /
Highlights of the minutes of GHTF-SG2 compiled by Carl Wallroth during the meeting in Canberra, Australia on 18 and 19 February[removed]Chair: Larry Kessler, FDA, USA Acting Secretary: Carl Wallroth, Dräger, Germany, EU